Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands
Public ClinicalTrials.gov record NCT04080882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.
Study identification
- NCT ID
- NCT04080882
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- AbobotulinumtoxinA dose 1 Biological
- Placebo Other
- AbobotulinumtoxinA dose 2 Biological
- AbobotulinumtoxinA dose 3 Biological
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 24, 2019
- Primary completion
- Dec 29, 2019
- Completion
- Jun 3, 2020
- Last update posted
- Aug 25, 2022
2019 – 2020
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Research Site | Encinitas | California | 92024 | — |
| Galderma Research Site | Encino | California | 91436 | — |
| Galderma Research Site | Boynton Beach | Florida | 33472 | — |
| Galderma Research Site | Miami | Florida | 33137 | — |
| Galderma Research Site | New Orleans | Louisiana | 70115 | — |
| Galderma Research Site | New Orleans | Louisiana | 70130 | — |
| Galderma Research Site | Baltimore | Maryland | 21208 | — |
| Galderma Research Site | New York | New York | 10028 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04080882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04080882 live on ClinicalTrials.gov.